James M. Cleary, MD, PhD: Increasingly, hospitals—including mine—have pathways that tell us what the recommended treatments are for our patients at a certain course in their illness. At my hospital, ...
Syma Iqbal, MD, shares final insights into the ESCC and GI cancer treatment landscape, emphasizing the utilization of key diagnostic tools and innovative treatment strategies. Syma Iqbal, MD: In terms ...
The poster also demonstrates endogenous receptor activity in CHO-K1 and HEK-293 cell lines stably expressing the GloSensor plasmid. In addition, transfected Gs- and Gi-coupled receptor activity are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback